Effect of Gliadin on Permeability of Intestinal Biopsy Explants From Celiac and Non-Celiac Gluten Sensitivity Patients
Justin Hollon, Alessio Fasano · Controlled clinical trial (ex vivo)
BlueRipple Assessment
This study examined whether gliadin — a component of gluten — increases “leaky gut,” the intestinal permeability hypothesized to drive inflammation, using tissue biopsies from celiac and non-celiac individuals.
Gliadin exposure increased permeability across all groups, including people with non-celiac gluten sensitivity and even some controls, with the greatest effect in active celiac disease. The work is associated with Alessio Fasano’s research on the gut-barrier protein zonulin and the broader hypothesis linking intestinal permeability to systemic inflammation.
The connection to cardiovascular disease is indirect and speculative — chronic low-grade inflammation is a cardiovascular risk factor, and gut barrier integrity is one proposed contributor — but this study is about intestinal physiology, not the heart, and uses a small ex vivo sample.
We rate the evidence moderate-to-limited. It is a competent mechanistic study in a niche area; its relevance to cardiovascular prevention is several inferential steps removed and unproven.
The original source
Hollon J, Puppa EL, Greenwald B, Goldberg E, Guerrerio A, Fasano A. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients. 2015 Feb 27;7(3):1565-1576.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.